Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Martin Beaulieu

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Frontiers in Psychiatry|January 29, 2019
Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New ProspectsAntonio Rampino, Aleksandra Marakhovskaia, Tiago Soares-Silva, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2004
Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutantGonzalo E Torres, Ava L Sweeney, Jean-Martin Beaulieu, et al.
Biological Psychiatry|May 23, 2006
Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animalsAli Salahpour, Ivan O Medvedev, Jean-Martin Beaulieu, et al.
Behavioral Neuroscience|January 29, 2019
Motor learning deficits and striatal GSK-3 hyperactivity in Akt3 knockout miceBruno Ouimet, Élise Pépin, Yan Bergeron, et al.
Frontiers in Molecular Neuroscience|May 1, 2018
Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic NeurotransmissionJivan Khlghatyan, Alesya Evstratova, Simon Chamberland, et al.
Biological Psychiatry|January 12, 2013
The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disordersJoëlle Lavoie, Placido Illiano, Tatyana D Sotnikova, et al.
Scientific Reports|November 21, 2015
Repetitive transcranial magnetic stimulation induces long-lasting changes in protein expression and histone acetylationAdeline Etiévant, Stella Manta, Camille Latapy, et al.
Molecular Pharmacology|July 17, 2014
Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmicsHugo Poulin, Iva Bruhova, Quadiri Timour, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 23, 2020
Region-specific effects of acute haloperidol in the human midbrain, striatum and cortexChristian Ole Wächtler, Karima Chakroun, Mareike Clos, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2008
Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychoticsBernard Masri, Ali Salahpour, Michael Didriksen, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Frontiers in Psychiatry|January 29, 2019
Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New ProspectsAntonio Rampino, Aleksandra Marakhovskaia, Tiago Soares-Silva, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2004
Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutantGonzalo E Torres, Ava L Sweeney, Jean-Martin Beaulieu, et al.
Biological Psychiatry|May 23, 2006
Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animalsAli Salahpour, Ivan O Medvedev, Jean-Martin Beaulieu, et al.
Behavioral Neuroscience|January 29, 2019
Motor learning deficits and striatal GSK-3 hyperactivity in Akt3 knockout miceBruno Ouimet, Élise Pépin, Yan Bergeron, et al.
Frontiers in Molecular Neuroscience|May 1, 2018
Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic NeurotransmissionJivan Khlghatyan, Alesya Evstratova, Simon Chamberland, et al.
Biological Psychiatry|January 12, 2013
The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disordersJoëlle Lavoie, Placido Illiano, Tatyana D Sotnikova, et al.
Scientific Reports|November 21, 2015
Repetitive transcranial magnetic stimulation induces long-lasting changes in protein expression and histone acetylationAdeline Etiévant, Stella Manta, Camille Latapy, et al.
Molecular Pharmacology|July 17, 2014
Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmicsHugo Poulin, Iva Bruhova, Quadiri Timour, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 23, 2020
Region-specific effects of acute haloperidol in the human midbrain, striatum and cortexChristian Ole Wächtler, Karima Chakroun, Mareike Clos, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2008
Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychoticsBernard Masri, Ali Salahpour, Michael Didriksen, et al.
Pageof 9